Lene Palhaugen
Oslo, Norway
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Independent prognostic value of peak width of skeletonized mean diffusivity on clinical progression in Alzheimer's disease.
Journal: Alzheimer's & dementia (Amsterdam, Netherlands)
Published: February 20, 2026
Genomic analyses reveal new insights into Alzheimer's disease.
Journal: medRxiv : the preprint server for health sciences
Published: November 24, 2025
Blood-brain barrier water exchange in relation to amyloid, cognition and cerebrovascular burden.
Journal: NeuroImage. Clinical
Published: July 28, 2025
Genotype-phenotype interaction in Alzheimer's disease immune activation.
Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: April 17, 2025
Comparison of CSF neurofilament light chain and total tau as neurodegeneration markers: Associations with synaptic markers and cognitive outcomes.
Journal: Neurobiology of aging
Published: March 06, 2025
Repeated plasma p-tau217 measurements to monitor clinical progression heterogeneity.
Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: February 04, 2025
Cerebrospinal fluid markers link to synaptic plasticity responses and Alzheimer's disease genetic pathways.
Journal: Molecular neurodegeneration
Published: November 26, 2024
Sexual dimorphisms in innate immune activation markers in predementia Alzheimer's disease.
Journal: Brain communications
Published: October 11, 2024
Age-adjusted CSF t-tau and NfL do not improve diagnostic accuracy for prodromal Alzheimer's disease.
Age-adjusted CSF t-tau and NfL do not improve diagnostic accuracy for prodromal Alzheimer's disease.
Journal: Neurobiology of aging
Published: December 20, 2023
Plasma brain-derived tau is an amyloid-associated neurodegeneration biomarker in Alzheimer's disease.
Journal: Nature communications
Published: August 09, 2023
Last Updated: 09/26/2026